Guys
PRR was also mentioned on YMYC another night earlier in the week. Query was expected Nasdaq benefit and panelist said
"I've looked at many small companies with Nasdaq listings and none have benefited in a big way from US listing".
message was that it helps but its not worth rivers of gold.
I still believe we should be 60-70 cents year end, $1 in 2013, $1.50 to $2 in 2014.
Justification- None other than guess based on successful trials and ultimate FDA approval.
your money your call, page-48
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 36.0¢ | 34.5¢ | $670.1K | 1.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 44785 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 22453 | 2 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |